Search
Partnership calls to combat eye treatment delays
Latest news, posted 1 July 2022
The Macular Society is working closely with health bodies across Wales in order to help them combat delays to eye care treatment in the country.
‘I was downhearted but Skills for Seeing lifted me’
Latest news, posted 1 July 2022
A volunteer trainer has shared his experience of the Skills for Seeing service, which offers one-to-one advice to help people make the best use of their remaining vision.
Gene editing to treat inherited macular disease
Latest news, posted 5 July 2022
A research team is making strides in using gene-editing techniques to treat a rare, inherited form of macular disease.
Eat for your eyes - how food is important for our sight
Latest news, posted 6 July 2022
What are the best foods to eat to look after your eyes?
Double donations for Amazon Prime Day
Latest news, posted 7 July 2022
The Macular Society will benefit from double donations on eligible purchases made by Amazon Prime members later this month, helping us to raise vital funds for macular research.
Cheaper drugs for wet AMD becoming available on the NHS
Latest news, posted 19 July 2022
New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.
New treatment option approved for patients with diabetic macular oedema
Latest news, posted 28 July 2022
Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).
New National Clinical Director for Eye Care appointed
Latest news, posted 1 August 2022
A new role which could help transform eye care services for people living with macular disease and other sight conditions, has been appointed by NHS England.
"It could be life-changing for so many people"
Latest news, posted 3 August 2022
A 75-year-old man involved in a clinical trial for a new implant for wet age-related macular degeneration (AMD) says it would be ‘magic’ if the trial is successful.
Ophthalmologist to reveal more about new drug for two types of macular disease
Latest news, posted 3 August 2022
An ophthalmologist who has worked on the clinical trials for the latest drug approved to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) will reveal more about the treatment and how you can access it, as part of the Macular Society’s monthly webinar series.